Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.8 (
hypoxanthine-guanine phosphoribosyltransferase
)
2,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Lowe
oculocerebrorenal syndrome
(
OCRL
) is characterized by congenital cataract, mental retardation, and renal tubular dysfunction. We are using the approaches of linkage analysis, mapping with somatic cell hybrids, and long-range restriction mapping to determine the order of Xq24-q26 markers with respect to each other and to the
OCRL
locus. DXS42 and DXS100 are proximal to the translocation breakpoint in a female patient with
OCRL
and a de novo translocation t(X;3)(q25;q27). DXS10, DXS86,
HPRT
, and DXS177 are distal to the breakpoint. These flanking markers show tight linkage to the disease locus in 11 families segregating for
OCRL
. Results from field inversion gel analysis show that DXS86 and DXS10 share a 460-kb BssHII fragment. Multipoint analysis to determine the position of
HPRT
with respect to (DXS10,DXS86) suggests that
HPRT
is proximal to (DXS10,DXS86). We propose the following order for markers in Xq24-q26: Xcen-(DXS42,DXS37,DXS100)-
OCRL
-DXS53 -
HPRT
-[(DXS10,DXS86),DXS177]-Xqter. The identification of additional tightly linked flanking markers extends the number of markers available for use in genetic counseling and begins to define the physical map of the region containing the gene for
OCRL
.
...
PMID:Genetic and physical mapping of Xq24-q26 markers flanking the Lowe oculocerebrorenal syndrome. 208 1